Literature DB >> 18618319

Antidiabetic effect of an active fraction extracted from dragon's blood (Dracaena Cochinchinensis).

Hui-Juan Gu1, Jing-Ci Lv, Ke-Lan Yong, Xu Chen, Pei-Pei Liu, Xia-Bing Zhang.   

Abstract

The active fraction extracted from dragon's blood displayed an inhibitory effect on alpha-glucosidase activity with an IC50 of 0.152 microg/mL, which is nearly half of the crude material. Its inhibition on alpha-glucosidase was noncompetitive. In addition, when this fraction was orally administered to mice dosed with Acarbose (20 mg/kg), the active fraction (100, 300, 500 mg/kg) significantly suppressed increase of blood glucose levels after sucrose loading in a dose-dependent manner. These results suggest that this extract from dragon's blood exerts an anti-diabetic effect by suppressing intestinal carbohydrate absorption and thereby reducing the postprandial increase of blood glucose.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18618319     DOI: 10.1080/14756360801936399

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  3 in total

1.  Sanguis draconis, a dragon's blood resin, attenuates high glucose-induced oxidative stress and endothelial dysfunction in human umbilical vein endothelial cells.

Authors:  Yi Chang; Ting-Chen Chang; Jie-Jen Lee; Nen-Chung Chang; Yung-Kai Huang; Cheuk-Sing Choy; Thanasekaran Jayakumar
Journal:  ScientificWorldJournal       Date:  2014-06-02

2.  Isolated compounds from Dracaena angustifolia Roxb and acarbose synergistically/additively inhibit α-glucosidase and α-amylase: an in vitro study.

Authors:  Jiling Yi; Ting Zhao; Yuanlin Zhang; Yanxing Tan; Xiao Han; Yulin Tang; Guangying Chen
Journal:  BMC Complement Med Ther       Date:  2022-07-02

3.  Dragon's Blood Regulates Rac1-WAVE2-Arp2/3 Signaling Pathway to Protect Rat Intestinal Epithelial Barrier Dysfunction Induced by Simulated Microgravity.

Authors:  Yujuan Li; Shan Liu; Huayan Liu; Yaoyuan Cui; Yulin Deng
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.